Development of antiviral therapy for severe acute respiratory syndrome.

Cinatl, Jindrich, Michaelis, Martin, Hoever, Gerold, Preiser, Wolfgang, Doerr, Hans Wilhelm (2005) Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Research, 66 (2-3). pp. 81-97. ISSN 0166-3542. (doi:10.1016/j.antiviral.2005.03.002) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:34109)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided.
Official URL: http://dx.doi.org/10.1016/j.antiviral.2005.03.002

Abstract

A new disease, the severe acute respiratory distress syndrome (SARS), caused by the SARS coronavirus (SARS-CoV), emerged at the beginning of 2003 and rapidly spread throughout the world. Although the disease had disappeared in June 2003 its re-emergence cannot be excluded. The development of vaccines against SARS-CoV may take years. Therefore, the availability of effective antiviral drugs against SARS-CoV may be crucial for the control of future SARS outbreaks. In this review, experimental and clinical data about potential anti-SARS drugs is summarised and discussed. Animal model studies will be needed to help to determine which interventions warrant controlled clinical testing.

Item Type:	Article
DOI/Identification number:	10.1016/j.antiviral.2005.03.002
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Divisions:	Divisions > Division of Natural Sciences > Biosciences
Depositing User:	Martin Michaelis
Date Deposited:	05 Jun 2013 20:37 UTC
Last Modified:	16 Nov 2021 10:11 UTC
Resource URI:	https://kar.kent.ac.uk/id/eprint/34109 (The current URI for this page, for reference purposes)

University of Kent Author Information

Michaelis, Martin.

Creator's ORCID:	https://orcid.org/0000-0002-5710-5888
CReDIT Contributor Roles:

Depositors only (login required):

Altmetric

Download Statistics

Total unique views for this document in KAR since July 2020. For more details click on the image.